Skip to main content
. 2015 Apr 10;10(4):e0121592. doi: 10.1371/journal.pone.0121592

Fig 4. Comparison of OSM+ of the present cohort (42 patients) with OSM+ of a cohort of GBM/ GS patients with exclusive CNS dissemination (84 patients).

Fig 4

Detailed information on characteristics and treatments of these 84 patients and on data collection has been reported previously [9].